Cargando…

Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand

BACKGROUND: Cardiac resynchronization therapy (CRT) improves symptoms and survival in patients with heart failure (HF). However, the CRT devices are costly and can impose a significant burden to the relatively constrained health budgets of middle-income countries such as Thailand. The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Permsuwan, Unchalee, Phrommintikul, Arintaya, Silavanich, Voratima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569046/ https://www.ncbi.nlm.nih.gov/pubmed/33116697 http://dx.doi.org/10.2147/CEOR.S268553

Ejemplares similares

Economic Burdens for Treatment of Patients With Type 2 Diabetes in North Thailand: A Hospital-Based Observational Study
por: Phrommintikul, Arintaya, et al.
Publicado: (2022)

Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction
por: Krittayaphong, Rungroj, et al.
Publicado: (2019)

Cost–Utility Analysis of Transcatheter Aortic Valve Implantation versus Surgery in High-Risk Severe Aortic Stenosis Patients in Thailand
por: Permsuwan, Unchalee, et al.
Publicado: (2022)

Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand
por: Yamwong, Sukit, et al.
Publicado: (2014)

Treatment Costs for Patients with Chronic Kidney Disease Who Received Multidisciplinary Care in a District Hospital in Thailand
por: Songsermlosakul, Suwaporn, et al.
Publicado: (2020)

Safety outcomes of ticagrelor among patients with STE-ACS post streptokinase therapy-a retrospective observational study
por: Ueapornpanith, Phornpaka, et al.
Publicado: (2023)

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand
por: Permsuwan, Unchalee, et al.
Publicado: (2016)

Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand
por: Vareesangthip, Kriengsak, et al.
Publicado: (2022)

Cost–benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand
por: Deerochanawong, Chaicharn, et al.
Publicado: (2019)

The efficacy and safety outcomes of cardiac resynchronization therapy in patients with heart failure in Thailand: Phramongkutklao experience
por: Limprasert, Sarawuth, et al.
Publicado: (2021)

Cost–Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand
por: Deerochanawong, Chaicharn, et al.
Publicado: (2021)

Economic Burdens of Type 2 Diabetes Hospital Visits with Hypoglycemic Episodes in the Tertiary Care Setting in Thailand
por: Kosachunhanun, Natapong, et al.
Publicado: (2023)

Discounting money and health effects from communicable and noncommunicable diseases in Thailand
por: Yadee, Jirawit, et al.
Publicado: (2023)

Influenza vaccination in acute coronary syndromes patients in Thailand: the cost-effectiveness analysis of the prevention for cardiovascular events and pneumonia
por: Sribhutorn, Apirak, et al.
Publicado: (2018)

Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
por: Deerochanawong, Chaicharn, et al.
Publicado: (2023)

Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
por: Deerochanawong, Chaicharn, et al.
Publicado: (2023)

Outcomes of Cardiac Resynchronization Therapy in Patients with Hypothyroidism and Heart Failure
por: Yang, Mei, et al.
Publicado: (2020)

Cardiac resynchronization therapy in heart failure patients with atrial fibrillation
por: Gasparini, Maurizio, et al.
Publicado: (2009)

Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure
por: Osmanska, Joanna, et al.
Publicado: (2018)

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure
por: Schrage, Benedikt, et al.
Publicado: (2021)

Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) database
por: Suwankesawong, Wimon, et al.
Publicado: (2014)

Cardiac Resynchronization Therapy prevents progression of renal failure in heart failure patients
por: Jeevanantham, Vinodh, et al.
Publicado: (2016)

Influenza Vaccination among Patients with Diabetes or Ischemic Heart Disease in Thailand: Coverage, Knowledge and Associated Factors †
por: Chinwong, Surarong, et al.
Publicado: (2023)

Aerobic exercise prescription in heart failure patients with cardiac resynchronization therapy
por: Tedjasukmana, Deddy, et al.
Publicado: (2020)

Cardiac resynchronization therapy in patients with mild heart failure is a reversal therapy
por: Ali-Hassan-Sayegh, Sadegh, et al.
Publicado: (2017)

Mortality and Heart Failure After Upgrade to Cardiac Resynchronization Therapy
por: Beca, Bogdan, et al.
Publicado: (2019)

Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review
por: Teimourizad, Abedin, et al.
Publicado: (2021)

An unusual failure of cardiac resynchronization therapy
por: Higuchi, Satoshi, et al.
Publicado: (2022)

Monocyte Subsets in Patients with Chronic Heart Failure Treated with Cardiac Resynchronization Therapy
por: Ptaszyńska-Kopczyńska, Katarzyna, et al.
Publicado: (2021)

The Effect of Concomitant Cardiac Resynchronization Therapy on Quality of Life in Patients with Heart Failure Undergoing Cardiac Surgery
por: Thorén, Emma, et al.
Publicado: (2014)

‘Inked the skin deep through the heart’: cardiac sarcoidosis after eyebrow tattooing
por: Osataphan, Nichanan, et al.
Publicado: (2022)

Systolic heart failure and cardiac resynchronization therapy: a focus on diastole
por: Facchini, Emanuela, et al.
Publicado: (2014)

Effect of Exercise Training in Heart Failure Patients Without Echocardiographic Response to Cardiac Resynchronization Therapy
por: Yanagi, Hidetoshi, et al.
Publicado: (2019)

MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure
por: Breithardt, Günter
Publicado: (2009)

Remote Hemodynamic‐Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy
por: Varma, Niraj, et al.
Publicado: (2021)

Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis
por: Sun, Hui, et al.
Publicado: (2015)

Utilization of cardiac resynchronization therapy in patients with heart failure in the Northern Region of New Zealand
por: Looi, Khang‐Li, et al.
Publicado: (2018)

Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy
por: Ptaszynska-Kopczynska, Katarzyna, et al.
Publicado: (2016)

Cardiac resynchronization therapy in heart failure patients by using left bundle branch pacing
por: Gu, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v5mvql3oh9iq6c2eqss2f07q4m